Dermacaine en es it fr

Dermacaine Brand names, Dermacaine Analogs

Dermacaine Brand Names Mixture

  • No information avaliable

Dermacaine Chemical_Formula

C21H27NO

Dermacaine RX_link

No information avaliable

Dermacaine fda sheet

Dermacaine FDA

Dermacaine msds (material safety sheet)

Dermacaine MSDS

Dermacaine Synthesis Reference

No information avaliable

Dermacaine Molecular Weight

309.445 g/mol

Dermacaine Melting Point

No information avaliable

Dermacaine H2O Solubility

No information avaliable

Dermacaine State

Solid

Dermacaine LogP

4.86

Dermacaine Dosage Forms

Tablets for oral administration (25 mg, 50 mg)

Dermacaine Indication

For use in the prevention and symptomatic treatment of peripheral (labyrinthine) vertigo and associated nausea and vomiting that occur in such conditions as Meniere's disease and surgery of the middle and inner ear. Also for the control of nausea and vomiting associated with postoperative states, malignant neoplasms, labyrinthine disturbances, antineoplastic agent therapy, radiation sickness, and infectious diseases.

Dermacaine Pharmacology

No information avaliable

Dermacaine Absorption

Well absorbed from gastrointestinal tract following oral administration.

Dermacaine side effects and Toxicity

Symptoms of overdose include drowsiness (severe); shortness of breath or troubled breathing; unusual tiredness or weakness (severe).

Dermacaine Patient Information

No information avaliable

Dermacaine Organisms Affected

Humans and other mammals